On September 16, 2024, Joan M. Lewis notified the board of directors (the “Board”) of Malibu Boats, Inc., a Delaware corporation (the “Company”), that she does not intend to stand for re-election at the Company’s 2024 annual meeting of stockholders (the “2024 Annual Meeting”).
Departed
Patricia Gibbs
Senior Vice President and Chief Accounting Officer
On September 16, 2024, Patricia Gibbs notified NETSTREIT Corp. (the “Company) of her intention to resign from her position of Senior Vice President and Chief Accounting Officer (“CAO”) and principal accounting officer (“PAO”) of the Company to pursue another opportunity.
Departed
Sabra Purtill
Executive Vice President and Chief Financial Officer
Executive Vice President and Chief Financial Officer Sabra Purtill who, upon Mr. Walsh’s commencement of employment, will work on strategic projects and act as an advisor to Mr. Walsh to enable a smooth transition.
Departed
Christina Van Tassell
Executive Vice President and Chief Financial Officer
On September 18, 2024, John Wiley & Sons, Inc. (the “Company”) announced that Christina Van Tassell, Executive Vice President and Chief Financial Officer, will be leaving the Company on October 1, 2024.
On September 13, 2024, Lih Shyng (Rick L.) Tsai, Ph.D. and Leslie F. Varon, members of the board of directors (the “Board”) of Lam Research Corporation (the “Company”), each notified the Company that they will conclude their service as members of the Board on November 4, 2024, prior to the Company’s 2024 annual meeting of stockholders.
On September 13, 2024, Lih Shyng (Rick L.) Tsai, Ph.D. and Leslie F. Varon, members of the board of directors (the “Board”) of Lam Research Corporation (the “Company”), each notified the Company that they will conclude their service as members of the Board on November 4, 2024, prior to the Company’s 2024 annual meeting of stockholders.
James J. Kim informed Amkor Technology, Inc. (the “Company”) that he will step down as Executive Chairman of the Company’s Board of Directors (the “Board”), effective October 31, 2024.
On September 13, 2024, Katrina Houde, notified SunOpta, Inc. ("SunOpta" or the "Company"), that she intends to resign from her position as a member of the Company's Board of Directors effective September 16, 2024, in order to focus on other opportunities.
Departed
Xavier Heiss
Executive Vice President and Chief Financial Officer
XEROX CORP
Effective
2025-01-31
Successor
Mirlanda Gecaj
Filed
September 18, 2024, 7:59 PM ET
On September 17, 2024, the Company announced that Xavier Heiss, Executive Vice President and Chief Financial Officer of Xerox Holdings Corporation and Xerox Corporation (collectively, the “Company”), will retire from the Company effective January 31, 2025.
Caroline M. Chambers, President, EMEA, will depart the Company effective December 31, 2024.
Departed
Richard Scheller, Ph.D.
Director
Chrome Holding Co.
Effective
2024-09-17
Filed
September 18, 2024, 7:59 PM ET
On September 17, 2024, the following non-employee directors of the Board of Directors (the “Board”) of 23andMe Holding Co. (the “Company”) resigned from the Board (the “Resignations”), with such Resignations to be effective immediately: Roelof Botha, Patrick Chung, Sandra Hernández, M.D., Neal Mohan, Valerie Montgomery Rice, M.D., Richard Scheller, Ph.D., and Peter J. Taylor (collectively, the “Resigning Directors”).
Departed
Patrick Chung
Director
Chrome Holding Co.
Effective
2024-09-17
Filed
September 18, 2024, 7:59 PM ET
On September 17, 2024, the following non-employee directors of the Board of Directors (the “Board”) of 23andMe Holding Co. (the “Company”) resigned from the Board (the “Resignations”), with such Resignations to be effective immediately: Roelof Botha, Patrick Chung, Sandra Hernández, M.D., Neal Mohan, Valerie Montgomery Rice, M.D., Richard Scheller, Ph.D., and Peter J. Taylor (collectively, the “Resigning Directors”).
Departed
Valerie Montgomery Rice, M.D.
Director
Chrome Holding Co.
Effective
2024-09-17
Filed
September 18, 2024, 7:59 PM ET
On September 17, 2024, the following non-employee directors of the Board of Directors (the “Board”) of 23andMe Holding Co. (the “Company”) resigned from the Board (the “Resignations”), with such Resignations to be effective immediately: Roelof Botha, Patrick Chung, Sandra Hernández, M.D., Neal Mohan, Valerie Montgomery Rice, M.D., Richard Scheller, Ph.D., and Peter J. Taylor (collectively, the “Resigning Directors”).
Departed
Peter J. Taylor
Director
Chrome Holding Co.
Effective
2024-09-17
Filed
September 18, 2024, 7:59 PM ET
On September 17, 2024, the following non-employee directors of the Board of Directors (the “Board”) of 23andMe Holding Co. (the “Company”) resigned from the Board (the “Resignations”), with such Resignations to be effective immediately: Roelof Botha, Patrick Chung, Sandra Hernández, M.D., Neal Mohan, Valerie Montgomery Rice, M.D., Richard Scheller, Ph.D., and Peter J. Taylor (collectively, the “Resigning Directors”).
Departed
Neal Mohan
Director
Chrome Holding Co.
Effective
2024-09-17
Filed
September 18, 2024, 7:59 PM ET
On September 17, 2024, the following non-employee directors of the Board of Directors (the “Board”) of 23andMe Holding Co. (the “Company”) resigned from the Board (the “Resignations”), with such Resignations to be effective immediately: Roelof Botha, Patrick Chung, Sandra Hernández, M.D., Neal Mohan, Valerie Montgomery Rice, M.D., Richard Scheller, Ph.D., and Peter J. Taylor (collectively, the “Resigning Directors”).
Departed
Sandra Hernández, M.D.
Director
Chrome Holding Co.
Effective
2024-09-17
Filed
September 18, 2024, 7:59 PM ET
On September 17, 2024, the following non-employee directors of the Board of Directors (the “Board”) of 23andMe Holding Co. (the “Company”) resigned from the Board (the “Resignations”), with such Resignations to be effective immediately: Roelof Botha, Patrick Chung, Sandra Hernández, M.D., Neal Mohan, Valerie Montgomery Rice, M.D., Richard Scheller, Ph.D., and Peter J. Taylor (collectively, the “Resigning Directors”).
Departed
Roelof Botha
Director
Chrome Holding Co.
Effective
2024-09-17
Filed
September 18, 2024, 7:59 PM ET
On September 17, 2024, the following non-employee directors of the Board of Directors (the “Board”) of 23andMe Holding Co. (the “Company”) resigned from the Board (the “Resignations”), with such Resignations to be effective immediately: Roelof Botha, Patrick Chung, Sandra Hernández, M.D., Neal Mohan, Valerie Montgomery Rice, M.D., Richard Scheller, Ph.D., and Peter J. Taylor (collectively, the “Resigning Directors”).
Departed
Peter Ingram
Director
HAWAIIAN HOLDINGS INC
Effective
2024-09-18
Filed
September 18, 2024, 7:59 PM ET
Wendy Beck, Earl Fry, Lawrence Hershfield, Jayne Hrdlicka, Peter Ingram, Michael McNamara, Crystal Rose, Craig Vosburg and Richard Zwern, each of whom was a director of Hawaiian as of immediately prior to the Effective Time, ceased to be a director of Hawaiian and a member of any committee of Hawaiian’s Board of Directors.
Departed
Craig Vosburg
Director
HAWAIIAN HOLDINGS INC
Effective
2024-09-18
Filed
September 18, 2024, 7:59 PM ET
Wendy Beck, Earl Fry, Lawrence Hershfield, Jayne Hrdlicka, Peter Ingram, Michael McNamara, Crystal Rose, Craig Vosburg and Richard Zwern, each of whom was a director of Hawaiian as of immediately prior to the Effective Time, ceased to be a director of Hawaiian and a member of any committee of Hawaiian’s Board of Directors.
Departed
Earl Fry
Director
HAWAIIAN HOLDINGS INC
Effective
2024-09-18
Filed
September 18, 2024, 7:59 PM ET
Wendy Beck, Earl Fry, Lawrence Hershfield, Jayne Hrdlicka, Peter Ingram, Michael McNamara, Crystal Rose, Craig Vosburg and Richard Zwern, each of whom was a director of Hawaiian as of immediately prior to the Effective Time, ceased to be a director of Hawaiian and a member of any committee of Hawaiian’s Board of Directors.
Departed
Jayne Hrdlicka
Director
HAWAIIAN HOLDINGS INC
Effective
2024-09-18
Filed
September 18, 2024, 7:59 PM ET
Wendy Beck, Earl Fry, Lawrence Hershfield, Jayne Hrdlicka, Peter Ingram, Michael McNamara, Crystal Rose, Craig Vosburg and Richard Zwern, each of whom was a director of Hawaiian as of immediately prior to the Effective Time, ceased to be a director of Hawaiian and a member of any committee of Hawaiian’s Board of Directors.
Departed
Richard Zwern
Director
HAWAIIAN HOLDINGS INC
Effective
2024-09-18
Filed
September 18, 2024, 7:59 PM ET
Wendy Beck, Earl Fry, Lawrence Hershfield, Jayne Hrdlicka, Peter Ingram, Michael McNamara, Crystal Rose, Craig Vosburg and Richard Zwern, each of whom was a director of Hawaiian as of immediately prior to the Effective Time, ceased to be a director of Hawaiian and a member of any committee of Hawaiian’s Board of Directors.
Departed
Lawrence Hershfield
Director
HAWAIIAN HOLDINGS INC
Effective
2024-09-18
Filed
September 18, 2024, 7:59 PM ET
Wendy Beck, Earl Fry, Lawrence Hershfield, Jayne Hrdlicka, Peter Ingram, Michael McNamara, Crystal Rose, Craig Vosburg and Richard Zwern, each of whom was a director of Hawaiian as of immediately prior to the Effective Time, ceased to be a director of Hawaiian and a member of any committee of Hawaiian’s Board of Directors.
Departed
Shannon Okinaka
Other Named Officer
HAWAIIAN HOLDINGS INC
Effective
2024-09-18
Filed
September 18, 2024, 7:59 PM ET
Peter Ingram, Aaron Alter and Shannon Okinaka resigned from their positions as officers of Hawaiian.
Departed
Crystal Rose
Director
HAWAIIAN HOLDINGS INC
Effective
2024-09-18
Filed
September 18, 2024, 7:59 PM ET
Wendy Beck, Earl Fry, Lawrence Hershfield, Jayne Hrdlicka, Peter Ingram, Michael McNamara, Crystal Rose, Craig Vosburg and Richard Zwern, each of whom was a director of Hawaiian as of immediately prior to the Effective Time, ceased to be a director of Hawaiian and a member of any committee of Hawaiian’s Board of Directors.
Departed
Wendy Beck
Director
HAWAIIAN HOLDINGS INC
Effective
2024-09-18
Filed
September 18, 2024, 7:59 PM ET
Wendy Beck, Earl Fry, Lawrence Hershfield, Jayne Hrdlicka, Peter Ingram, Michael McNamara, Crystal Rose, Craig Vosburg and Richard Zwern, each of whom was a director of Hawaiian as of immediately prior to the Effective Time, ceased to be a director of Hawaiian and a member of any committee of Hawaiian’s Board of Directors.
Departed
Aaron Alter
Other Named Officer
HAWAIIAN HOLDINGS INC
Effective
2024-09-18
Filed
September 18, 2024, 7:59 PM ET
Peter Ingram, Aaron Alter and Shannon Okinaka resigned from their positions as officers of Hawaiian.
Departed
Michael McNamara
Director
HAWAIIAN HOLDINGS INC
Effective
2024-09-18
Filed
September 18, 2024, 7:59 PM ET
Wendy Beck, Earl Fry, Lawrence Hershfield, Jayne Hrdlicka, Peter Ingram, Michael McNamara, Crystal Rose, Craig Vosburg and Richard Zwern, each of whom was a director of Hawaiian as of immediately prior to the Effective Time, ceased to be a director of Hawaiian and a member of any committee of Hawaiian’s Board of Directors.
Departed
Peter Ingram
Other Named Officer
HAWAIIAN HOLDINGS INC
Effective
2024-09-18
Successor
Joseph Sprague
Filed
September 18, 2024, 7:59 PM ET
Peter Ingram, Aaron Alter and Shannon Okinaka resigned from their positions as officers of Hawaiian.
Departed
John E. Bailey, Jr.
Other Named Officer
G1 Therapeutics, Inc.
Filed
September 18, 2024, 7:59 PM ET
each of John E. Bailey, Jr., Mark Avagliano, Rajesh K. Malik, M.D., Terry L. Murdock, and John W. Umstead V ceased serving as an officer of the Company
Departed
John E. Bailey, Jr.
director
G1 Therapeutics, Inc.
Filed
September 18, 2024, 7:59 PM ET
each of John E. Bailey, Jr., Cynthia L. Flowers, Jacks Lee, Glenn P. Muir, Garry A. Nicholson, Alicia Secor and Norman E. Sharpless, M.D. resigned as directors of the Company
Departed
Jacks Lee
director
G1 Therapeutics, Inc.
Filed
September 18, 2024, 7:59 PM ET
each of John E. Bailey, Jr., Cynthia L. Flowers, Jacks Lee, Glenn P. Muir, Garry A. Nicholson, Alicia Secor and Norman E. Sharpless, M.D. resigned as directors of the Company
Departed
Cynthia L. Flowers
director
G1 Therapeutics, Inc.
Filed
September 18, 2024, 7:59 PM ET
each of John E. Bailey, Jr., Cynthia L. Flowers, Jacks Lee, Glenn P. Muir, Garry A. Nicholson, Alicia Secor and Norman E. Sharpless, M.D. resigned as directors of the Company
Departed
Mark Avagliano
Other Named Officer
G1 Therapeutics, Inc.
Filed
September 18, 2024, 7:59 PM ET
each of John E. Bailey, Jr., Mark Avagliano, Rajesh K. Malik, M.D., Terry L. Murdock, and John W. Umstead V ceased serving as an officer of the Company
Departed
John W. Umstead V
Other Named Officer
G1 Therapeutics, Inc.
Filed
September 18, 2024, 7:59 PM ET
each of John E. Bailey, Jr., Mark Avagliano, Rajesh K. Malik, M.D., Terry L. Murdock, and John W. Umstead V ceased serving as an officer of the Company
Departed
Rajesh K. Malik, M.D.
Other Named Officer
G1 Therapeutics, Inc.
Filed
September 18, 2024, 7:59 PM ET
each of John E. Bailey, Jr., Mark Avagliano, Rajesh K. Malik, M.D., Terry L. Murdock, and John W. Umstead V ceased serving as an officer of the Company
Departed
Terry L. Murdock
Other Named Officer
G1 Therapeutics, Inc.
Filed
September 18, 2024, 7:59 PM ET
each of John E. Bailey, Jr., Mark Avagliano, Rajesh K. Malik, M.D., Terry L. Murdock, and John W. Umstead V ceased serving as an officer of the Company
Departed
Alicia Secor
director
G1 Therapeutics, Inc.
Filed
September 18, 2024, 7:59 PM ET
each of John E. Bailey, Jr., Cynthia L. Flowers, Jacks Lee, Glenn P. Muir, Garry A. Nicholson, Alicia Secor and Norman E. Sharpless, M.D. resigned as directors of the Company
Departed
Norman E. Sharpless, M.D.
director
G1 Therapeutics, Inc.
Filed
September 18, 2024, 7:59 PM ET
each of John E. Bailey, Jr., Cynthia L. Flowers, Jacks Lee, Glenn P. Muir, Garry A. Nicholson, Alicia Secor and Norman E. Sharpless, M.D. resigned as directors of the Company
Departed
Garry A. Nicholson
director
G1 Therapeutics, Inc.
Filed
September 18, 2024, 7:59 PM ET
each of John E. Bailey, Jr., Cynthia L. Flowers, Jacks Lee, Glenn P. Muir, Garry A. Nicholson, Alicia Secor and Norman E. Sharpless, M.D. resigned as directors of the Company
Departed
Glenn P. Muir
director
G1 Therapeutics, Inc.
Filed
September 18, 2024, 7:59 PM ET
each of John E. Bailey, Jr., Cynthia L. Flowers, Jacks Lee, Glenn P. Muir, Garry A. Nicholson, Alicia Secor and Norman E. Sharpless, M.D. resigned as directors of the Company
On September 18, 2024, Five Below, Inc. (the “Company”) and Michael F. Romanko, the Company’s Chief Merchandising Officer, entered into an agreement (the “Cessation Agreement”) providing for Mr. Romanko’s retirement and the cessation of his employment with the Company, effective as of November 17, 2024.
On September 15, 2024, Jonathan Maroko notified Faraday Future Intelligent Electric Inc. (the “Company”) of his decision to resign from his position as Interim Chief Financial Officer of the Company, effective September 20, 2024.
Departed
Shrisha Radhakrishna
Chief Technology Officer and Chief Product Officer
On September 13, 2024, Shrisha Radhakrishna resigned from his positions as Chief Technology Officer and Chief Product Officer of LegalZoom.com, Inc. (the “Company”) to pursue other opportunities, with such resignation to be effective November 15, 2024.
On September 17, 2024, Sarah Bond and Dr. Paul LeBlanc, each members of the Board of Directors (the “Board”) of Chegg, Inc. (the “Company”), notified the Company of their respective decisions to resign from the Board, effective September 18, 2024.
On September 17, 2024, Sarah Bond and Dr. Paul LeBlanc, each members of the Board of Directors (the “Board”) of Chegg, Inc. (the “Company”), notified the Company of their respective decisions to resign from the Board, effective September 18, 2024.
Departed
Stephen Branstetter
Chief Operating Officer
SMARTSHEET INC
Effective
2024-09-18
Filed
September 18, 2024, 7:59 PM ET
On September 13, 2024, Stephen Branstetter, the Chief Operating Officer of Smartsheet Inc. (the "Company") notified the Company of his decision to resign from his position, effective September 18, 2024.
On September 13, 2024, Linda R. Evans, the Company's Chief Human Resources Officer, provided notice of her intention to retire as of January 2, 2025.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.